The percentage abundance of sarcomatoid component has a prognostic role in grade 4 non-metastatic clear cell-renal carcinoma

被引：0
|
作者：
Giuseppe Lucarelli [1 ]
Francesco Lasorsa [1 ]
Monica Rutigliano [1 ]
Martina Milella [1 ]
Marco Spilotros [1 ]
Antonio d’Amati [2 ]
Giuseppe Ingravallo [2 ]
Felice Crocetto [3 ]
Savio Domenico Pandolfo [3 ]
Marco Fabiano [4 ]
Matteo Ferro [5 ]
Riccardo Autorino [6 ]
Michele Battaglia [7 ]
Pasquale Ditonno [1 ]
机构：
[1] University of Bari “Aldo Moro”,Urology, Andrology and Kidney Transplantation Unit, Department of Precision and Regenerative Medicine and Ionian Area
[2] University of Bari “Aldo Moro”,Pathology Unit, Department of Precision and Regenerative Medicine and Ionian Area
[3] University of Naples Federico II,Department of Neurosciences, Reproductive Sciences and Odontostomatology
[4] University of L’Aquila,Department of Urology
[5] “Antonio Cardarelli” Hospital,Division of Urology
[6] University of Milan,Urology Unit, Department of Health Science
[7] Rush University Medical Center,Department of Urology
来源：
World Journal of Urology | / 43卷 / 1期
关键词：
Renal cell carcinoma; Sarcomatoid; Grading; Percentage; Prognosis;
D O I：
10.1007/s00345-025-05630-4
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [11] Erratum to: Prognostic factors of metastatic renal cell carcinoma with extensive sarcomatoid component
    Inkeun Park
    Yong Mee Cho
    Jae-Lyun Lee
    Jin-Hee Ahn
    Dae-Ho Lee
    Cheryn Song
    Jun-Hyuk Hong
    Choung-Soo Kim
    Hanjong Ahn
    Journal of Cancer Research and Clinical Oncology, 2013, 139 : 1777 - 1779
  • [12] Renal parenchymal infiltration or micronodular spread in non-metastatic clear cell renal cell carcinoma: Prognostic impact and genomic backgrounds
    Tanaka, H.
    Fukawa, Y.
    Yamamoto, K.
    Tanimoto, K.
    Takemoto, A.
    Hasumi, H.
    Hirakawa, A.
    Ishikawa, Y.
    Fukuda, S.
    Waseda, Y.
    Yoshida, S.
    Yokoyama, M.
    Campbell, S. C.
    Fujii, Y.
    EUROPEAN UROLOGY, 2023, 83 : S668 - S669
  • [13] Treatment obstacles for metastatic clear cell renal cell carcinoma of Fahrman grade IV and with sarcomatoid histologies
    Czarnecka, Anna Malgorzata
    Gebara-Puchniarz, Agnieszka
    Nowak-Dement, Anna
    Micluk, Beata
    Solarek, Wojciech
    Szczyllk, Cezary
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [14] Serum soluble B7-H4 is a prognostic marker for patients with non-metastatic clear cell renal cell carcinoma
    Azuma, Takeshi
    Sato, Yujiro
    Ohno, Tetsukuni
    Azuma, Miyuki
    Kume, Haruki
    PLOS ONE, 2018, 13 (07):
  • [15] Percentage grade 4 tumour predicts outcome for clear cell renal cell carcinoma
    Dagher, Julien
    Delahunt, Brett
    Rioux-Leclercq, Nathalie
    Egevad, Lars
    Varma, Murali
    Samaratunga, Hemamali
    PATHOLOGY, 2019, 51 (04) : 349 - 352
  • [16] A preoperative clinical prognostic model for non-metastatic renal cell carcinoma
    Cindolo, L
    de la Taille, A
    Messina, G
    Romis, L
    Abbou, CC
    Altieri, V
    Rodriguez, A
    Patard, JJ
    BJU INTERNATIONAL, 2003, 92 (09) : 901 - 905
  • [17] DNA methylation associates with survival in non-metastatic clear cell renal cell carcinoma
    Emma Andersson Evelönn
    Mattias Landfors
    Zahra Haider
    Linda Köhn
    Börje Ljungberg
    Göran Roos
    Sofie Degerman
    BMC Cancer, 19
  • [18] Immunomodulatory response to neoadjuvant nivolumab in non-metastatic clear cell renal cell carcinoma
    Singla, Nirmish
    Nirschl, Thomas R.
    Obradovic, Aleksandar Z.
    Shenderov, Eugene
    Lombardo, Kara
    Liu, Xiaopu
    Pons, Alice
    Zarif, Jelani C.
    Rowe, Steven P.
    Trock, Bruce J.
    Hammers, Hans J.
    Bivalacqua, Trinity J.
    Pierorazio, Phillip M.
    Deutsch, Julie S.
    Lotan, Tamara L.
    Taube, Janis M.
    Ged, Yasser M. A.
    Gorin, Michael A.
    Allaf, Mohamad E.
    Drake, Charles G.
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [19] Immunomodulatory response to neoadjuvant nivolumab in non-metastatic clear cell renal cell carcinoma
    Nirmish Singla
    Thomas R. Nirschl
    Aleksandar Z. Obradovic
    Eugene Shenderov
    Kara Lombardo
    Xiaopu Liu
    Alice Pons
    Jelani C. Zarif
    Steven P. Rowe
    Bruce J. Trock
    Hans J. Hammers
    Trinity J. Bivalacqua
    Phillip M. Pierorazio
    Julie S. Deutsch
    Tamara L. Lotan
    Janis M. Taube
    Yasser M. A. Ged
    Michael A. Gorin
    Mohamad E. Allaf
    Charles G. Drake
    Scientific Reports, 14
  • [20] Prognostic value of granulocyte colony-stimulating factor in patients with non-metastatic clear cell renal cell carcinoma
    Liu, Zheng
    Zhu, Yu
    Wang, Yiwei
    Fu, Qiang
    Fu, Hangcheng
    Wang, Zewei
    Zhang, Junyu
    Li, Gaoxiang
    Xu, Jiejie
    Dai, Bo
    ONCOTARGET, 2017, 8 (41) : 69961 - 69971
12345